Rocket Pharmaceuticals CEO Gaurav Shah sells $7,752 in shares
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
More in Health & Medicine
Fiji's HIV epidemic has yet to reach a 'turning point', minister warns
Fiji is now in a generalised HIV epidemic, which means the virus is firmly established and spreading within the general population.
UnitedHealthcare expands behavioral coaching program for youths
UnitedHealthcare is expanding access to its child and family behavioral coaching program, making it available to 13 million commercial members.
The healthcare change that has some veterans furious
Jacqui Lambie's emotional moment in the Senate taps into veteran fury over a government change to healthcare access.
Schwartz recognizes CDC strife in first talks with staff
Click in for more news from The Hill {beacon} Healthcare Healthcare The Big Story Schwartz recognizes CDC strife in first talks with staff Erica Schwartz, the newly confirmed director of the Centers…
Enugu govt, dietician warn against using adulterated oil, colourant for Okpa delicacy
Nwachukwu said Okpa, made from Bambara nut, naturally contained appreciable amounts of protein, fat, carbohydrates and essential minerals such as iron and zinc.
Congo to receive 70,000 doses of Ervebo Ebola vaccine, which was effective in past outbreaks
WHO said in a statement that while it's not known whether Ervebo may protect against the Bundibugyo virus, "early laboratory and animal data suggest it may provide some protection."